Search

March 28, 2014 - A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and the Heart Rhythm Society; developed in collaboration with the Society of Thoracic Surgeons.  The goal of this guideline is to establish revised guidelines for optimum management of atrial fibrillation. This guideline supersedes the "2006 ACC/AHA/ESC Guideline for the Management of Patients with Atrial Fibrillation" and the two subsequent focused updates from 2011.

This document has been retired and replaced by the 2017 publication available at this link.

March 2012 — The purpose of the 2012 Consensus Statement is to provide a state-of-the-art review of the field of catheter and surgical ablation of AFib. It reports  on the findings of a Task Force, convened by the Heart Rhythm Society (HRS), the European Heart Rhythm Association (EHRA), and the European Cardiac Arrhythmia Society (ECAS) and charged with defining the indications, techniques, and outcomes of this procedure.

February 14, 2011 — This guideline update, states that dabigatran, a new antithrombotic agent that was recently approved by the U.S. Food and Drug Administration, is an alternative to warfarin to help prevent dangerous blood clots in patients with atrial fibrillation. The update is a joint publication of the American College of Cardiology Foundation (ACCF), the American Heart Association (AHA), and the Heart Rhythm Society (HRS). 

This document has been retired and replaced by "2014 AHA/ACC/HRS Guideline for the Management of Patients with Atrial Fibrillation."

April 2003 — This consensus statement provides a simple way to characterize an episode of Atrial Fibrillation. It is the result of a collaborative project of the Working Group on Arrhythmias and the Working Group of Cardiac Pacing of the European Society of Cardiology and the North American Society of Pacing and Electrophysiology, now known as Heart Rhythm Society.

November 18, 2014 - The Heart Rhythm Society convened a research symposium on December 9–10, 2013, in Washington, DC, that focused on the prevention of atrial fibrillation (AF) as well as AF-related stroke and morbidity.Attendees sought to summarize advances in understanding AF since a 2008 National Institutes of Health(NIH) conference on this topic and to identify continued knowledge gaps and current research priorities.  This resultant whitepaper was developed in collaboration with and endorsed by the European Heart Rhythm Association (EHRA) and the Canadian Heart Rhythm Society (CHRS). It summarizes the deliberations of the attendees in an effort to accelerate progress toward preventing AF and its consequences.

June 29, 2015 - The American College of Cardiology (ACC), the Heart Rhythm Society (HRS), and the Society for Cardiovascular Angiography and Interventions (SCAI) have collaborated in writing this overview as the first of a series of documents to address issues critical to the appropriate integration of new technologies into the care of patients with AF.